Therefore, the increased expression of TMPRSS2 in PRAD tissues increases the patients’ susceptibility to COVID-19 infection, which aggravates PRAD disease progression and severely lowers patients’ survival rate [19]. The gene discussed is TMPRSS2; the disease is prostate adenocarcinoma.